| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |